These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 8669314
1. [Arterial hypertension, left ventricular hypertrophy and cardiovascular risk]. Nogueira JB. Acta Med Port; 1995 Dec; 8(12):663-6. PubMed ID: 8669314 [No Abstract] [Full Text] [Related]
2. [Arterial hypertension, correlated factors and cardiovascular risk]. Pessina AC, Casiglia E, Rossi GP, Semplicini A. Cardiologia; 1991 Dec; 36(12 Suppl 1):67-78. PubMed ID: 1841807 [Abstract] [Full Text] [Related]
3. Arterial hypertension and cardiovascular damage in the elderly: focus on arterial stiffness and left ventricular hypertrophy. Paciaroni E, Antonicelli R, Gambini C, Sirolla C. Clin Exp Hypertens; 1993 Dec; 15 Suppl 1():1-7. PubMed ID: 8513302 [Abstract] [Full Text] [Related]
4. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study]. Ibsen H, Pedersen OL, Dahlöf B, Kjeldsen SE, Lindholm LH. Ugeskr Laeger; 2003 Jan 27; 165(5):456-9. PubMed ID: 12599843 [Abstract] [Full Text] [Related]
5. Left ventricular hypertrophy: a potent cardiovascular risk factor and its relationship to office and ambulatory blood pressure. Mansoor GA, Massie BM. Blood Press Monit; 1999 Jan 27; 4 Suppl 1():S19-22. PubMed ID: 10822413 [Abstract] [Full Text] [Related]
8. The effect of losartan compared with atenolol on the incidence of revascularization in patients with hypertension and electrocardiographic left ventricular hypertrophy. The LIFE study. Olsen MH, Wachtell K, Dahlöf B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Lyle PA, Nieminen MS. J Hum Hypertens; 2006 Jun 27; 20(6):460-4. PubMed ID: 16572193 [No Abstract] [Full Text] [Related]
10. Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE study). Smebye ML, Iversen EK, Høieggen A, Flaa A, Os I, Kjeldsen SE, Olsen MH, Chattopadhyay A, Hille DA, Lyle PA, Devereux RB, Dahlöf B. Am J Cardiol; 2007 Sep 01; 100(5):855-9. PubMed ID: 17719333 [Abstract] [Full Text] [Related]
16. [On the connection between left ventricular hypertrophy and diastolic dysfunction in arterial hypertension]. Trushinskiĭ ZK, Dovgaliuk IuV, Skritskaia OIu. Ter Arkh; 2003 Feb 01; 75(3):57-9. PubMed ID: 12718223 [Abstract] [Full Text] [Related]
18. Left ventricular hypertrophy as a risk factor in hypertension. Balogun MO, Dunn FG. Afr J Med Med Sci; 1996 Sep 01; 25(3):277-83. PubMed ID: 10457806 [Abstract] [Full Text] [Related]